NOVEL OCTAPEPTIN ANTIBIOTICS TARGETING EXTREMELY DRUG RESISTANT 'SUPERBUGS'
Grant number: 1128891 | Funding period: 2017 - 2021
The World Health Organization (WHO) has identified antimicrobial resistance as one of the three greatest threats to human health. Many clinicians worldwide have already been confronted with the reality of infections caused by extremely drug resistant (XDR) bacterial 'superbugs' resistant to all available antibiotics. This project aims to develop safe and efficacious octapeptin antibiotics for the treatment of life-threatening infections caused by problematic XDR ‘superbugs'.